The Centers for Medicare & Medicaid Services (CMS) added two new Current Procedural Terminology (CPT) codes for administration of monoclonal antibodies (Nirsevimab) for respiratory syncytial virus (RSV), for dates of service on and after Oct. 6, 2023.
- 96380 – This provider administers a monoclonal antibody product to protect the patient against respiratory syncytial virus. This is a seasonal dose injected into muscle. A physician or other qualified healthcare professional also provides counseling related to the administration.
- 96381 – This provider administers a monoclonal antibody product to protect the patient against respiratory syncytial virus. This is a seasonal dose injected into muscle.
More information can be found on the CMS or AMA websites. Members with questions may contact Kelsey Ostergren at the MHA.